References
1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective
Studies collaboration.
Age specific relevance of usual blood pressure to vascular mortality. A
meta-analysis
of individual data for a million adult in 61 prospective studies.
Prospective studies
collaboration. The Lancet 2002; 360: 1903 - 13.
2. Ruitenberg A, Skoog I, Ott A, Aevarsson O, Witteman, JC, Lernfelt B,
et al. Blood
pressure and risk of dementia: result from the Rotterdam study and the
Gothenberg
H-70 study. Dement Geriatric Cogn Disord 2001; 12: 33 - 9.
3. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular
and other risk
Factors for Alzheimer’s disease and vascular dementia. Ann N Y Acad
Sci 2000; 903:
411 - 23.
4. B. Sabayan, L. W. Wijsman, J. C. Foster - Dingley et al. Association
of visit-to-visit
variability in blood pressure with cognitive function in old age:
prospective cohort study.
BMJ 2013; 347: f4600.
5. N. U. Epstein, K. A. Lane, and M. R. Farlow et al. Cognitive
dysfunction and greater visit-
to-visit systolic blood pressure variability. Journal of the
American Geriatrics Society
2013; 61(12): 2168 - 73.
6. M. Nagai, S. Hoshide, M. Nishikawa, S. Masahisa, and K. Kario.
Visit-to-visit blood
pressure variability in the elderly: Associations with cognitive
impairment and
carotid artery remodelling. Atherosclerosis 2014; 233(1): 19 - 26.
7. Jawed RA. Midlife hypertension is associated with impaired cognition
and dementia
later. Clev Clin J Med 2002; 69: 664 - 9.
8. B. A. In’t Veld, A. Ruitenberg, A. Hofman, B. H. C. Stricker, M. M.
B. Breteler. Anti-
hypertensive drugs and incidence of dementia: The Rotterdam Study.
Neurobiology of
Aging 2001; 22(3): 407 - 12.
9. P. J. Tully, J.F. Dartigues, S. Debette, C. Helmer, S. Artero, C.
Tzourio. Dementia risk
with antihypertensive use and blood pressure variability. Neurology
2016; 87(6):
601 - 8.
10. S. Yasar, J. Xia, W. Yao et al. Antihypertensive drugs decrease risk
of Alzheimer
disease: Ginkgo Evaluation of Memory Study. Neurology 2013;
81(10): 896 - 903.
11. R. Stewart, Q. Xue, K. Masaki et al. Change in Blood Pressure and
Incident Dementia:
A 32-Year Prospective Study. Hypertension 2009; 54(2): 233 - 40.
12. B. Haring, C. Wu, L. H. Coker et al. Hypertension, Dietary Sodium
and Cognitive decline:
Results from the Women’s Health Initiative Memory Study. American
Journal of
Hypertension 2016; 29(2): 202 - 16.
13. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C,
Handler J,
Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC. 2014
evidence -
based guideline for the management of high blood pressure in adults:
report from
the panel members appointed to the Eighth Joint National
Committee (JNC 8).
JAMA 2014; 311(5): 507 - 20.
14. Forette F., Seux M.-L., Staessen J. A., et al. The prevention of
dementia with anti -
hypertensive treatment: new evidence from the systolic
hypertension in Europe (Syst -
Eur) study. Archives of Internal Medicine 2002; 162(18): 2046 -
52.
15. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM,
Faure S, Mazouz H,
Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black
S, Sato N. prevention
of Dementia by Antihypertensive Drugs: How AT1-receptor-blockers
and Dihydro - pyridines Better Prevent Dementia in Hypertensive Patients
than Thiazides and
ACE-inhibitors. Expert Rev Neurother 2009; 9(9): 1413 - 31.
PMID: 19769454.
16. Jean K.Ho, Daniel A Nation & for the Alzheimer’s Disease
Neuroimaging Initiative.
Memory is preserved in older adults taking AT1 receptor
Blockers. Alzheimer’s
Research & Therapy 2017; 9: 33. DOI 10.1186/s13195-017-0255-9.
17. Bulpitt CJ, Fletcher AE. Cognitive function and
angiotensin-converting enzyme
inhibitors in comparison with other antihypertensive drugs. J
Cardiovasc Pharmacol
1992; 19(Suppl 6): S100 - 04.
18. Efimova IY, Efimova NY, Triss SV, Lishmanov YB. Brain perfusion
and cognitive function
changes in hypertensive patients. Hypertens Res 2008; 31: 673 -
78.
19. Ekta Arora, Vijay Khajuria, Vishal R. Tandon, Atul Sharma, Naiyma
Choudhary.
Comparative evaluation of aliskiren, ramipril, and losartan on
psychomotor
performance in healthy volunteers: A preliminary report.
Perspectives in Clinical
Research 2014; 5(4): 190 - 94.
20. KavitaRathore, Sunil Kumar Mathur Comparative Study of two ARBs on
Memory and
Psychomotor Functions in Mild to Moderate Hypertension. IJSR
2016; 5(9): 531 - 33.
21. Puram NN, Karande VB, Ramanand JB, Ramanand SJ, Halasawadekar NR,
Bhosale RR.
Comparison of efficacy of telmisartan with losartan in patients
of essential
hypertension with cognitive impairment. Int J Basic Clin
Pharmacol 2016; 5: 702 - 6.
22. KavitaRathore, Sunil Kumar Mathur. Comparative Study of
Telmisartan Alone and With
Atorvastatin On Cognitive Functions in Mild to Moderate
Hypertensive Patients.
Indian Journal of Applied Research (IJAR) 2016; 6(9): 647 - 50.
23. C. Bachmeier, D. Beaulieu-Abdelahad, M. Mullan, D. Paris.
Selective dihydropyiridine
compounds facilitate the clearance of beta-amyloid across the
blood-brain barrier.
Eur. J. Pharmacol 2011; 659: 124 - 29.
24. S. Lesné, T. K. Ming, L. Kotilinek et al. A specific amyloid-β
protein assembly in the
brain impairs memory. Nature 2006; 440 (7082): 352 - 357.
25. V Nimmrich, A Eckert. Calcium channel blockers and dementia.
British Journal of
Pharmacology (BJP) 2013; 169: 1203 - 10.
26. Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F. New
pharmacological
strategies for treatment of Alzheimer’s disease: focus on
disease modifying drugs.
Br J Clin Pharmacol 2012; 73: 504 - 17.
27. Mukesh Madhukar Shete. Cilnidipine: Next Generation Calcium Channel
Blocker.
J Assoc Physicians India 2016; 64(4): 95 - 99.
28. Pershad D, Wig NN. A battery of simple tests of memory for use in
India. Neurol India
1976; 24: 86 - 93. [PubMed: 1012437]
29. Pershad D, Wig NN. Relationship between PGI Memory scale and WAIS
verbal I.Q.
Neurol India 1979; 27: 69 - 72.
30. R Fogari, A Mugellini, A Zoppi, G Derosa, C Pasotti, E Fogari and
P Preti. Influence of
losartan and atenolol on memory function in very elderly
hypertensive patients.
Journal of Human Hypertension 2003; 17: 781 - 785.
31. Gore PN, Badar VA, Hardas MM, Bansode VJ, Navale SB. Comparative
effects of
Telmisartan and Lisinopril on cognitive function in metabolic
syndrome patients.
Int J Clin Exp Physiol 2014; 1: 216 - 20.
32. M Stuhec, J Keuschler, J Serra-Mestres, M Isetta. Effects of
Different Antihypertensive
Medication Groups on Cognitive Function in Older Patients: A
Systematic Review.
Eur Psychiatry 2017; 46: 1 - 15.
33. Ashok Jaiswal, V. Bhavsar, Jaykaran, N. D. Kantharia. Effect of
antihypertensive
therapy on cognitive functions of patients with hypertension.
Ann Indian Acad
Neurol 2010; 13(3): 180 - 183.